Methods
We designed orthogonal-based discrete choice experiment (DCE), which incorporated six COVID-19 vaccine attributes (Additional file 1: Table S1) into 18 choice scenarios (Additional file 1: Table S2), to reveal COVID-19 vaccine preferences among university students. The survey questionnaire was developed for this study (Additional file 2). Data was collected using web-based survey tool Qualtrics (Qualtrics, Provo, UT) between 25th January and 25th February 2021—the date before the Hong Kong Government officially launched the mass vaccination scheme. The online questionnaire was distributed by snowballing methods through social media and university mass emails. Conditional logit regression was used to estimate the preference weight of each attribute [3]. Ethics approval was obtained from Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (UW-20-792).
Results
We received 194 (71.1%) completed DCE responses from 270 respondents in eight University Grants Committee-funded institutions in Hong Kong. The participants were predominately aged 18–22 years, of which 60% are studying medical-related subjects (Additional file 1: Table S3). As indicated by the regression coefficient, non-severe adverse reactions, efficacy, origin of the vaccine, required number of doses and out-of-pocket price are significant determinants for the choice of vaccine, ranked from the most to least important. Adjusted by age, sex, monthly household income, studying medical-related subjects and recent influenza vaccination, the model yielded similar preference weighting results. Safety, efficacy, and origin of the vaccine remained the top three influential factors for vaccine preferences in both models (Fig. 1). Studying medical-related subjects [Odds Ratio (OR) 0.987; 95% Confidence Interval (CI) 0.858–1.136] or having received influenza vaccine recently [1.026 (0.887–1.188)] showed marginal impact in the decision process (data not shown).
Discussion
In line with the global vaccination recommendation to university students, almost all Hong Kong higher educations have recently announced COVID-19 vaccination as a condition for campus residency, which requires all students and staff to take the vaccine or have regular testing [4]. This is a crucial time to understand vaccine preferences among university students to optimize health education and vaccine supply. In the current study, vaccine safety, efficacy and origin are the most influential determinants of vaccine choices among the university students in Hong Kong, independent of demo-socioeconomic status, medical knowledge, and influenza vaccination. Students are willing to have vaccines with less adverse reactions, higher efficacy, and more doses to achieve a good immune response. Of note, vaccines originating from overseas, but not Hong Kong or Mainland China, are highly preferred with over 65% increased likelihood of taking the vaccine. The results are consistent with previous studies showing that perceived risk-benefits of the vaccine, confidence in the healthcare system and vaccine manufacturers are key drivers for vaccine acceptance [5, 6]. This further highlights an imperative need to convey evidence-based safety and efficacy information for all available vaccines in the licensed region. Persistent effort should be made to foster confidence in government and manufacturers to improve vaccine supply and acceptance.
Conclusion
University students in Hong Kong preferred vaccines with superior safety and efficacy profiles and vaccines manufactured overseas. Transparent evidence showing the safety and efficacy/effectiveness of vaccines from different origins is urgently needed to overcome vaccine hesitancy among university students in Hong Kong.
